On this page you will find a repository of national and international guidance for health professionals on cancer management and COVID-19. The page is no longer being actively maintained. For advice specific to the health sector, please refer to the Department of Health and Aged Care's website.
[accordion]
Australia & New Zealand
Australian & New Zealand Children’s Haematology/Oncology Group (ANZCHOG)
COVID-19 Vaccination Guidance for children 12 years and older undergoing cancer treatment and children with non-cancerous blood disorders
Date: 06-Sep-2021
Audience: Australian and New Zealand paediatric oncology community
Purpose: Guidance for paediatric cancer clinicians and other healthcare professionals caring for children with cancer in relation to the COVID-19 vaccine.
Te Aho o Te Kahu - New Zealand Cancer Control Agency
Te Aho o Te Kahu guidance for clinicians on COVID-19 vaccines and cancer
Date: 03-July-21
Audience: Health professionals
Purpose: Guidance on the use of the COVID-19 vaccines for clinicians involved with the care of cancer patients.
Medical Oncology Group of Australia (MOGA)
COVID-19 vaccination in patients with solid tumours position statement
Date: 21-Jun-2021
Audience: Medical oncologists and other health professionals
Purpose: Position statement for cancer clinicians and other healthcare professionals caring for people with cancer in relation to the COVID-19 vaccine.
The Royal Australian and New Zealand College of Radiologists (RANZCR)
The Royal Australian and New Zealand College of Radiologists Statement on Vaccine Induced Adenopathy
Date: 09-Jun-2021
Audience: Radiologists
Purpose: Guidance on vaccine induced adenopathy.
Melbourne Vaccine Education Centre
COVID-19 vaccines in people with immunocompromise
Date: 17-May-21
Audience: Health professionals
Purpose: Guidance on the use of COVID-19 vaccines for people who are immunocompromised, including cancer patients.
Australasian Society of Clinical Immunology and Allergy
Allergy, Immunodeficiency, Autoimmunity and COVID-19 Vaccination Position Statement
Date: 14-Apr-2021
Audience: Health professionals
Purpose: Guidance for healthcare providers and public health officials on the COVID-19 vaccine, including considerations for vaccination of immunocompromised people.
Queensland Health
COVID-19 vaccination advice for cancer patients
Date: 01-Apr-2021
Audience: Health professionals
Purpose: Guidance on the COVID-19 vaccine for clinicians and their cancer patients.
Haematology Society of Australia and New Zealand
COVID-19 Vaccination in Haematology Patients: An Australia and New Zealand Consensus Position Statement
Date: 02-Feb-2021
Audience: Haematologists and other health professionals
Purpose: Guidance on the COVID-19 vaccine for Haematology patients.
Australia and New Zealand Transplant and Cellular Therapies
Australia and New Zealand Transplant and Cellular Therapies COVID19 Vaccination Consensus Position Statement
Date: 20-Jan-2021
Audience: Haematologists and other health professionals
Purpose: Guidance on the COVID-19 vaccine for haematopoietic stem cell transplant and CAR-T cell (TCT) patients.
UK
Blood Cancer UK
Covid vaccine and blood cancer
Date: 20-Jul-2021
Audience: Health professionals
Purpose: Blog on the latest research and evidence in the area of the COVID-19 vaccine and blood cancer.
British Lymphology Society
Consensus document on COVID-19 vaccination for patients with lymphoedema
Date: 25-May-2021
Audience: Health professionals
Purpose: Consensus recommendations regarding COVID-19 vaccination for patients with lymphoedema:
UK Chemotherapy Board
Clinician Frequently Asked Questions (FAQs) and guidance on COVID-19 vaccine for patients receiving Systemic Anti-Cancer Therapy
Date: 09-May-2021
Audience: Medical oncologists and other health professionals
Purpose: Guidance on the COVID-19 vaccine for patients receiving systemic anti-cancer therapy.
USA
Centres for Disease Control and Prevention
Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Authorized in the United States
Date: 16-Jul-2021
Audience: Health professionals
Purpose: Guidance for healthcare providers and public health officials on the COVID-19 vaccine, including considerations for vaccination of immunocompromised people.
American Society of Clinical Oncology and Friends of Cancer Research
Inclusion of Individuals with Cancer on COVID-19 Vaccine Trials
Date: 22-June-2021
Audience: Health professionals and cancer patients
Purpose: Position statement on the inclusion of cancer patients in COVID-19 vaccine trials.
American Society of Clinical Oncology
COVID-19 Vaccine & Patients with Cancer
Date: 21-May-2021
Audience: Health professionals
Purpose: Q&A on the COVID-19 vaccine and its impact on patients with cancer.
National Comprehensive Cancer Network
Recommendations of the NCCN COVID-19 Vaccination Advisory Committee
Date: 09-Jun-2021
Audience: Oncology health professionals
Purpose: Guidance for COVID-19 vaccinations in people with cancer.
North American Neuroendocrine Tumor Society
NANETS’ Position Statement COVID-19 Vaccination for NEN patients
Date: 01-Feb-2021
Audience: Health professionals
Purpose: Position statement on the COVID-19 vaccine for patients with neuroendocrine neoplasms.
American Society for Radiation Oncology
ASTRO Recommendation on COVID-19 Vaccination for Cancer Patients Receiving Radiation Therapy
Date: 26-Jan-2021
Audience: Radiation oncology professionals
Purpose: Recommendation on the COVID-19 vaccine for cancer patients receiving radiation therapy.
Canada
Manitoba Government
Manitoba COVID-19 vaccine: Clinical practice guidelines for immunizers and health care providers
Date: 19-Jul-2021
Audience: Health professionals
Purpose: Recommendation on the COVID-19 vaccine for cancer patients.
British Columbia Ministry of Health
Clinical Guidance on COVID-19 Vaccines for People with Solid Cancers
Date: 20-Jun-2021
Audience: Health professionals
Purpose: Recommendation on the COVID-19 vaccine for cancer patients.
Europe
French Society for Immunotherapy of Cancer (FITC)
SARS-CoV-2 vaccines for cancer patients treated with immunotherapies: Recommendations from the French society for Immuno-Therapy of Cancer (FITC)
Date: 18-Feb-2021
Audience: Medical oncologists and other health professionals
Purpose: Recommendations on the COVID-19 vaccine for cancer patients treated with immunotherapy.
European Society for Medical Oncology (ESMO)
COVID-19 vaccination in patients with cancer: ESMO releases ten statements
Date: 22-Dec-2020
Audience: Medical oncologists and other health professionals
Purpose: Statements on the efficacy and safety of the COVID-19 vaccine in relation to cancer patients.
Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)
Guideline on evidence-based management of COVID-19 in cancer patients regarding diagnostics, viral shedding, vaccination and therapy
Date: 10-Feb-2021
Audience: Haematologists, medical oncologists and other health professionals
Purpose: Evidence-based recommendations for rapid diagnostics, viral shedding, vaccination and therapy of COVID-19 in cancer patients.
Asia
The Philippine Society of Medical Oncology
COVID-19 vaccine and patients with cancer
Date: 08-Apr-21
Audience: Health professionals
Purpose: Guidance on COVID-19 vaccination for cancer patients.
International
International Society of Geriatric Oncology
The SIOG COVID-19 working group recommendations on the rollout of COVID-19 vaccines among older adults with cancer
Date: 05-Mar-2021
Audience: Haematologists, medical oncologists and other health professionals
Purpose: Recommendations on the rollout of COVID-19 vaccines for older patients with cancer.
[/accordion]